Reports for NALOXONE

Ingredient

NALOXONE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
PMS-BUPRENORPHINE-NALOXONE 2MG 0.5MG TABLET Resolved 2017-03-14 2017-11-23 2352
PMS-BUPRENORPHINE-NALOXONE 2MG 0.5MG TABLET Avoided shortage 2019-03-29 2019-05-01 79878
PMS-BUPRENORPHINE-NALOXONE 2MG 0.5MG TABLET Resolved 2019-06-11 2019-07-03 86234
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2019-10-03 2020-01-24 95396
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2021-05-20 2021-06-03 139725
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2021-06-03 2021-06-10 140363
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2022-08-18 2022-12-02 167203
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Actual shortage 2024-03-07 2024-05-09 221534
MYLAN-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2017-03-22 2017-04-12 3922
MYLAN-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2017-04-20 2019-09-18 7392

Showing 11 to 20 of 23

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MYLAN-BUPRENORPHINE/NALOXONE 8MG 2MG TABLET Discontinued 2019-09-17 2019-09-18 94048
MYLAN-BUPRENORPHINE/NALOXONE Discontinued 2019-09-17 2019-09-18 94044

Showing 1 to 2 of 2